Strategic Analysis of the Antiarrhythmic Drugs Market Global Outlook The international landscape for cardiac pharmaceuticals is becoming increasingly interconnected as regulatory bodies seek to harmonize safety standards across borders. In 2026, we are seeing a "borderless" approach to clinical trials, where data from multiple continents is used to fast-track approvals for breakthrough heart...